Your browser doesn't support javascript.
loading
Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation.
Paredes, Roger; Tzou, Philip L; van Zyl, Gert; Barrow, Geoff; Camacho, Ricardo; Carmona, Sergio; Grant, Philip M; Gupta, Ravindra K; Hamers, Raph L; Harrigan, P Richard; Jordan, Michael R; Kantor, Rami; Katzenstein, David A; Kuritzkes, Daniel R; Maldarelli, Frank; Otelea, Dan; Wallis, Carole L; Schapiro, Jonathan M; Shafer, Robert W.
Afiliação
  • Paredes R; IrsiCaixa AIDS Research Institute, Badalona, Spain.
  • Tzou PL; Division of Infectious Diseases, Stanford University, Stanford, CA, United States of America.
  • van Zyl G; Division of Medical Virology, Stellenbosch University and NHLS Tygerberg, Cape Town, South Africa.
  • Barrow G; Centre for HIV/AIDS Research, Education and Services (CHARES), Department of Medicine, University of the West Indies, Kingston Jamaica.
  • Camacho R; Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Carmona S; Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa.
  • Grant PM; Division of Infectious Diseases, Stanford University, Stanford, CA, United States of America.
  • Gupta RK; UCL, Department of Infection, London, WC1E 6BT, United Kingdom.
  • Hamers RL; Amsterdam Institute for Global Health and Development, Department of Global Health, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
  • Harrigan PR; BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Jordan MR; Tufts University School of Medicine, Boston, MA, United States of America.
  • Kantor R; Division of Infectious Diseases, Alpert Medical School, Brown University, Providence, RI, United States of America.
  • Katzenstein DA; Division of Infectious Diseases, Stanford University, Stanford, CA, United States of America.
  • Kuritzkes DR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America.
  • Maldarelli F; HIV Dynamics and Replication Program, CCR, National Cancer Institute, NIH, Translational Research Unit, Frederick, MD, United States of America.
  • Otelea D; Molecular Diagnostics Laboratory, National Institute for Infectious Diseases, Bucharest, Romania.
  • Wallis CL; BARC-SA and Lancet Laboratories, Johannesburg, South Africa.
  • Schapiro JM; National Hemophilia Center, Tel Hashomer, Israel.
  • Shafer RW; Division of Infectious Diseases, Stanford University, Stanford, CA, United States of America.
PLoS One ; 12(7): e0181357, 2017.
Article em En | MEDLINE | ID: mdl-28753637
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: HIV-1 / Inibidores da Transcriptase Reversa / Fármacos Anti-HIV Tipo de estudo: Guideline Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: HIV-1 / Inibidores da Transcriptase Reversa / Fármacos Anti-HIV Tipo de estudo: Guideline Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha País de publicação: Estados Unidos